diabetes-symposium - faculty

Managing blood glucose lowering in the context of CAD: An independent view
27-Aug-12 , Munich, Germany

Self-monitoring of blood glucose – to be or not to be in non-insulin treated patients

State of the (HE)ART: CVD risk prediction and management
06-Dec-11 , Munich Diabetes Research Group + D&CVD EASD Study Group

World Diabetes Congress, Dubai, United Arab Emirates

Self-monitoring of blood glucose: Impact on CV risk in diabetes

4th Annual Meeting of the D&CVD EASD Study Group - Day 1
27-Oct-11 , Munich, Germany

Opening

In focus: New approaches for treatment support and cardiovascular risk management in diabetes
12-Sep-11 , Lisbon, Portugal

A collaborative intervention using structured self-monitoring of blood glucose shows a correlation between blood glucose control and markers of cardiovascular disease (CRP, NT-proBNP): Results of the STeP study

Testing with a purpose: Making SMBG worthwhile
20-Sep-10 , Stockholm, Sweden

Welcome and Introduction

Testing with a purpose: Making SMBG worthwhile
20-Sep-10 , Stockholm, Sweden

Exploration of SMBG Recommendations and Case based discussion of Issues and Solutions in View of International Guidelines

Testing with a purpose: Making SMBG worthwhile
20-Sep-10 , Stockholm, Sweden

A Case Presentation on type 2 diabetes and coronary artery disease

Testing with a purpose: Making SMBG worthwhile
20-Sep-10 , Stockholm, Sweden

Summary

Diabetes and Cardiovascular Disease: Pathways for prevention – Munich Diabetes Research Institute
10-Apr-10 , Dresden, Germany

Hypoglycemia: The neglected complication?

Diabetes, Prediabetes and CVD – the Need for Early Intervention
18-Oct-09 , Montreal, Canada

Recent guideline recommendations for managing pre- and established diabetes and CVD (Archiv)